Skip to content

Clinical trials

Phase 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 2 Country / region: United Kingdom Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20053
20063
20071
20103
20121
20134
20151
20181
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb6
Novartis Pharmaceuticals6
Teva Branded Pharmaceutical Products R&D, Inc.2
Agenus Inc.1
Ariad Pharmaceuticals1
European Society for Blood and Marrow Transplantation1
Imperial College London1
Lynn McMahon1
Pfizer1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive24
Precursor Cell Lymphoblastic Leukemia-Lymphoma6
Leukemia5
Leukemia, Myeloid, Acute5
Hematologic Diseases3
Leukemia, Myeloid, Chronic-Phase3
Myelodysplastic Syndromes3
Philadelphia Chromosome3
Bone Marrow Diseases2
Hodgkin Disease2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.